---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-045109"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T02:06:11.651862+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical CFO David R. Wells departs; CEO Lucas becomes interim CFO

## Summary
- David R. Wells ceased as CFO effective May 16, 2025, without cause.
- Wells entitled to separation benefits per his August 2023 employment agreement.
- CEO Brent T. Lucas will serve as interim principal financial officer.
- Search for a permanent successor CFO has been initiated.

## SEC filing metadata
- accession: 0001213900-25-045109
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/ea0242673-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-045109
- JSON: https://secwatch.observer/filing/0001213900-25-045109.json
- Plain text: https://secwatch.observer/filing/0001213900-25-045109.txt

## Key facts
- Executive change
  David R. Wells departed as Chief Financial Officer at Envoy Medical, Inc..
  - Action: ceased
  - Role: Chief Financial Officer
  source text: Effective May 16, 2025, David R. Wells ceased serving as Chief Financial Officer of Envoy Medical, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm
- Executive change
  Brent T. Lucas was appointed as principal financial officer at Envoy Medical, Inc..
  - Action: appointed
  - Role: principal financial officer
  source text: The Company’s Chief Executive Officer, Brent T. Lucas, will serve as principal financial officer on an interim basis until a successor Chief Financial Officer is appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.